Prolonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndrome

Digestive Diseases and Sciences

Volumn 41, Issue 3, 1996, Pages 604-613

  Orbuch, Murray ^b   Venzon, David J ^b   Lubensky, Irina A ^b   Weber, Horst C ^b   Gibril, Fathia ^b   Jensen, Robert T ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NONE

Author keywords

Colon cancer; Colon polyps; Hypergastrinemia; Omeprazole; Zollinger Ellison syndrome

Indexed keywords

OMEPRAZOLE;

ADULT; ARTICLE; CANCER RISK; COLON CANCER; COLON POLYP; CONTROLLED STUDY; FEMALE; HUMAN; HYPERGASTRINEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ZOLLINGER ELLISON SYNDROME;

ADENOCARCINOMA; ADENOMATOUS POLYPS; AGE DISTRIBUTION; CHRONIC DISEASE; COLONIC NEOPLASMS; COLONIC POLYPS; COLONOSCOPY; FASTING; FEMALE; GASTRINS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SEX DISTRIBUTION; ZOLLINGER-ELLISON SYNDROME;

EID: 0030008296     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02282349     Document Type: Article

References (89)

1. Creutzfeldt W: The achlorhydria-carcinoid sequence: Role of gastrin. Digestion 39:61-79, 1988
2. Maton PN, Dayal Y: Clinical implications of hypergastrinemia. In Peptic Ulcer Disease and Other Acid-Related Disorders. D Zakim, AJ Dannenberg (eds). Armonk, New York, Academic Research Associates, 1991, pp 213-246
3. Jensen RT: Gastrinoma as a model for prolonged hypergastrinemia in man. In Gastrin. JH Walsh (ed). New York, Raven Press, 1993, pp 373-393
4. Wormsley KG: Is chronic long-term inhibition of gastric secretion really dangerous? Scand J Gastroenterol Suppl 146:166-174, 1988
5. Pounder R, Smith J: Drug-induced changes of plasma gastrin concentration. Gastroenterol Clin North Am 19:141-153, 1990
6. Peterson WL: Helicobacter pylori and peptic ulcer disease. N Engl J Med 324:1043-1047, 1991
7. Smith JT, Pounder RE, Nwokolo CU, Lanzon-Miller S, Evans DG, Graham DY, Evans DJ Jr: Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut 31:522-525, 1990
8. Marks RD, Richter JE: Gastroesophageal reflux disease. In Peptic Ulcer Disease and Other Acid-related Disorders. D Zakim, AJ Dannenberg (eds). Armonk, New York, Academic Research Associates, 1991, pp 247-314
9. Kahrilas PJ, Hogan WJ: Gastroesophageal reflux disease. In Gastrointestinal Disease. MH Sleisenger, JS Fordtran (eds). Philadelphia, WB Saunders, 1993, pp 378-401
10. Hetzel DJ, Dent J, Reed WD, Narielvala FM, MacKinnon M, McCarthy JH, Mitchell B, Beveridge BR, Laurence BH, Gibson GG, Grant AK, Shearman DJ, Whitehead R, Buckle PJ: Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 95:903-912, 1988
11. Jansen JB, Klinkenberg-Knol EC, Meuwissen SG, De Bruijne JW, Festen HP, Snel P, Luckers AE, Biemond I, Lamers CB: Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis. Gastroenterology 99:621-628, 1990
12. Lamberts R, Creutzfeldt W, Struber HG, Brunner G, Solcia E: Long-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth, and gastritis. Gastroenterology 104:1356-1370, 1993
13. Ekman L, Hansson E, Havu N, Carlsson E, Lundberg C: Toxicological studies on omeprazole. Scand J Gastroenterol 20(suppl 108):53-69, 1985
14. Hakanson R, Sundler F: Mechanisms for the development of gastric carcinoids. Digestion 35(suppl 1):1-151, 1986
15. Havu N: Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 35(suppl 1):42-55, 1986
16. Townsend CM Jr, Ishizuka J, Thompson JC: Gastrin trophic effects on transplanted colon cancer cells. In Gastrin. JH Walsh (ed). New York, Raven Press, 1993, pp 407-417
17. Johnson LR, Guthrie PD: Progumide inhibition of trophic action of pentagastrin. Am J Physiol 246:G62-G66, 1984
18. Lamote J, Willems G: Stimulating effect of pentagastrin on cancer cell proliferation kinetics in chemically induced colon cancer in rats. Regul Pept 20:1-9, 1988
19. Sirinek KR, Levine BA, Moyer MP: Pentagastrin stimulates in vitro growth of normal and malignant human colon epithelial cells. Am J Surg 149:35-39, 1985
20. Pawlikowski M, Wajs E, Lewinski A, Szkudlinski M, Rybicka I, Sewerynek E: Effect of omeprazole-induced hypergastrinaemia on the proliferation of colonie mucosal epithelial cells in the rat. Exp Clin Endocrinol 97:50-54, 1991
21. Mak KM, Chang WWL: Pentagastrin stimulates epithelial cell proliferation in duodenal and colonie crypts in fasted rats. Gastroenterology 71:117-120, 1976
22. Pawlikowski M, Szkudlinski M, Lewinski A: Effects of pentagastrin, proglumide and cysteamine on proliferation of gastric and colonie mucosal epithelial cells in the rat. Med Sci Res 17:753-754, 1989
23. Ryan GP, Johnson LR: Role of gastrin in mucosal DNA synthesis after vagotomy and atropine in the rat. Am J Physiol 235:E565-E569, 1978
24. McGregor DB, Jones RD, Karlin DA, Romsdahl MM: Trophic effects of gastrin on colorectal neoplasms in the rat. Ann Surg 195:219-223, 1982
25. Karlin DA, McBath M, Jones RD, Elwyn KE, Romsdahl MM: Hypergastrinemia and colorectal carcinogenesis in the rat. Cancer Lett 29:73-78, 1985
26. Winsett OE, Townsend CM Jr, Glass EJ, Thompson JC: Gastrin stimulates growth of colon cancer. Surgery 99:302-307, 1986
27. McGregor DB, Morriss LL, Manalo PB, Bomberger RA, Pardini RS: Pentagastrin stimulation of human colon carcinoma. Arch Surg 124:470-472, 1989
28. Smith JP, Solomon TE: Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer. Gastroenterology 95:1541-1548, 1988
29. Singh P, Townsend CM Jr, Walker JP, Thompson JC: Gastrin receptors in a mouse colon cancer cell line responsive to trophic effects of gastrin. Surg Forum 35:205-206, 1984
30. Kusyk CJ, McNiel NO, Johnson LR: Stimulation of growth of colon cancer cell line by gastrin. Am J Physiol 251:G597-G601, 1986
31. Singh P, Walker JP, Townsend CM Jr, Thompson JC: Role of gastrin and gastrin receptors on the growth of a transplantable mouse colon carcinoma (MC-26) in Balb/c mice. Cancer Res 46:1612-1616, 1986
32. Upp JR Jr, Singh P, Townsend CM Jr, Thompson JC: The clinical significance of gastrin receptors in human colon cancers. Cancer Res 49:488-492, 1989
33. Smith JP, Wood JG, Solomon TE: Elevated gastrin levels in patients with colon cancer or adenomatous polyps. Dig Dis Sci 34:171-174, 1989
34. Wong K, Beardshall K, Waters CM, Calam J, Poston GJ: Postprandial hypergastrinaemia in patients with colorectal cancer. Gut 32:1352-1354, 1991
35. Seitz JF, Giovanni M, Gourvernet J, Gauthier AP: Elevated serum gastrin levels in patients with colorectal neoplasia. J Clin Gastroenterol 13:541-545, 1991
36. Suzuki H, Matsumoto K, Terashima H: Serum levels of gastrin in patients with colorectal neoplasia. Dis Colon Rectum 32:716-717, 1988
37. Yapp R, Modlin IM, Kumar RR, Binder HJ, Dubrow R: Gastrin and colorectal cancer. Evidence against an association. Dig Dis Sci 37:481-484, 1992
38. Sobhani I, Lehy T, Laurent-Puig P, Cadiot G, Ruszniewski P, Mignon M: Chronic endogenous hypergastrinemia in humans: Evidence for a mitogenic effect on the colonic mucosa. Gastroenterology 105:22-30, 1993
39. Brinton LA, Gridley G, Hrubeck Z, Hoover R, Fraumeni JF, Jr: Cancer risk following pernicious anaemia. Br J Cancer 89:810-813, 1989
40. Siurala M, Lehtola J, Ihamaki T: Atrophic gastritis and its sequelae. Scand J Gastroenterol 9:441-446, 1974
41. Elsborg L, Mosbech J: Pernicious anaemia as a risk factor in gastric cancer. Acta Med Scand 206:315-318, 1979
42. Freston JW: Clinical significance of hypergastrinaemia: relevance to gastrin monitoring during omeprazole therapy. Digestion 51:102-114, 1992
43. Hakanson R, Axelson J, Ekman R, Sundler F: Hypergastrinaemia evoked by omeprazole stimulates growth of gastric mucosa but not of pancreas of intestines in hamster, guinea pig and chicken. Regul Pept 23:105-115, 1988
44. Jensen RT, Gardner JD: Gastrinoma. In The Pancreas: Biology, Pathobiology and Disease. VLW Go, EP DiMagno, JD Gardner, E Lebenthal, HA Reber, GA Scheele (eds). New York, Raven Press, 1993, pp 931-978
45. Wolfe MM, Jensen RT: Zollinger-Ellison syndrome: Current concepts in diagnosis and management. N Engl J Med 317:1200-1209, 1987
46. Pisegna JR, Norton JA, Slimak GG, Metz DC, Maton PN, Jensen RT: Effects of curative resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome. Gastroenterology 102:767-778, 1992
47. Fishbeyn VA, Norton JA, Benya RV, Pisegna JR, Venzon DJ, Metz DC, Jensen RT: Assessment and prediction of long-term cure in patients with Zollinger-Ellison syndrome: The best approach. Ann Intern Med 119:199-206, 1993
48. O'Brien MJ, Winawer SJ, Zauber AG, Gottlieb LS, Sternberg SS, Dietz B, Dickersin GR, Ewing S, Geller S, Kasimian D, Komorowski R, Szporn A: The National polyp study: Patient and polyp characteristics associated with high-grade dysplasia in coloreclal adenomas. Gastroenterology 98:371-379, 1990
49. Cherner JA, Doppman JL, Norton JA, Miller DL, Krudy AG, Raufman JP, Collen MJ, Maton PN, Gardner JD, Jensen RT: Selective venous sampling for gastrin to localize gastrinomas. A prospective study. Ann Intern Med 105:841-847, 1986
50. Frucht H, Howard JM, Slaff JI, Wank SA, McCarthy DM, Maton PN, Vinayek R, Gardner JD, Jensen RT: Secretin and calcium provocative tests in the Zollinger-Ellison syndrome: A prospective study. Ann Intern Med 111:713-722, 1989
51. Weber HC, Venzon DJ, Lin JT, Fishbein VA, Orbuch M, Sirader DH, Gibril F, Metz DC, Fraker DL, Norton JA, Jensen RT: Determinants of melastatic rate and survival in patients with Zollinger-Ellison syndrome: A prospective long-term study. Gastroenterology 108:1637-1649, 1995
52. Benya RV, Metz DC, Venzon DJ, Fishbeyn VA, Strader DB, Orbuch M, Jensen RT: Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type 1. Am J Med 97:436-444, 1994
53. Metz DC, Pisegna JR, Fishbeyn VA, Benya RV, Jensen RT: Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome. World J Surg 17:468-480, 1993
54. Dawson-Saunders B, Trapp RG: Basic and Clinical Biostatistics. Norwalk. Connecticut, Appleton & Lange, 1990
55. DiSario JA, Foutch PG, Mai HD, Pardy K, Manne RK: Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men. Am J Gastroenterol 86:941-945, 1991
56. Johnson DA, Gurney MS, Volpe RJ, Jones DM, VanNess MM, Chobanian SJ, Avalos JC, Buck JL, Kooyman G, Cattau EL: A prospective study of the prevalence of colonic neoplasms in asymptomatic patients with an age-related risk. Am J Gastroenterol 85:969-974, 1990
57. Rex DK, Lehman GA, Ulbright TM, Smith JJ, Pound DC, Hawes RH, Helper DJ, Wiersema MJ, Langefeld CD, Li W: Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: Influence of age, gender, and family history. Am J Gastroenterol 88:825-831, 1993
58. Rex DK, Lehman GA, Hawes RH, Ulbright TM, Smith JJ: Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology 100:64-67, 1991
59. Rickert RR, Auerbach O, Garfinkel L, Hammond EC, Frasca JM: Adenomatous lesions of the large bowel: An autopsy survey. Cancer 43:1847-1857, 1979
60. Neugut AI, Jacobson JS, DeVivo I: Epidemiology of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev 2:159-176, 1993
61. Grossman S, Milos ML: Colonoscopic screening of persons with suspected risk factors for colon cancer - I. Family history. Gastroenterology 94:395-400, 1988
62. Mignon M, Ruszniewski P, Haffar S, Rignaud D, Rene E, Bonfils S: Current approach to the management of tumoral process in patients with gastrinoma. World J Surg 10:703-710, 1986
63. Jensen RT, Norton JA: Endocrine neoplasms of the pancreas. In Textbook of Gastroenterology, 1st ed. T Yamada, DH Alpers, C Owyang, DW Powell, FE Silverstein (eds). Philadelphia, JB Lippincott, 1991, pp 1912-1937
64. Richter G, Stockmann F, Lemhcke B, Conlon JM, Creutzfeld W: Short-term administration of the somatostatin analogue SMS 201-995 in patients with carcinoid syndrome. Scand J Gastroenterol 21:193, 1986
65. Jensen RT, Doppman JL, Gardner JD: Gastrinoma. In The Exocrine Pancreas: Biology, Pathohiology and Disease. VLW Go, FA Brooks, EP DiMagno, JD Gardner, E Lebenthal, GA Scheele (eds). New York, Raven Press, 1986, pp 727-744
66. Jensen RT, Dayal Y: Long-term clinical effects of hypergastrinemia in man. Regul Pept Lett 4:31-39, 1992
67. Townsend CM Jr, Singh P, Thompson JC: Effects of gastrointestinal peptides on gastrointestinal cancer growth. Gastroenterol Clin North Am 18:777-791, 1989
68. Hoosein NM, Kiener PA, Curry RC, Brattain MG: Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide. Exp Cell Res 186:15-21, 1990
69. Beauchamp RD, Townsend CM Jr, Singh P, Glass EJ, Thompson JC: Proglumide, a gastrin receptor antagonist, inhibits growth of colon cancer and enhances survival in mice. Ann Surg 202:303-309, 1985
70. Graffner H, Singh G, Chaudry I, Milsom JW: Omeprazole-induced hypergastrinemia does not influence growth of colon carcinoma. Dig Dis Sci 37:485-489, 1992
71. Eggstein S, Imdahl A, Kohler M, Waibel M, Farthmann EH: Influence of gastrin, gastrin receptor blockers, epidermal growth factor, and difluoromethylornithine on the growth of the activity of ornithine decarboxylase of colonie carcinoma cells. J Cancer Res Clin Oncol 117:37-42, 1991
72. Tatsuta M, Yamamura H, Ichii M, Taniguchi H: Effect of prolonged administration of gastrin on experimental carcinogenesis in rat colon induced by intrarectal instillation of N-methyl-N′-nitro-N-nitrosoguanidine. Cancer Res 43:2258-2260, 1983
73. Oscarson JE, Veen HF, Ross JS, Malt RA: Dimethylhydrazine-induced colonie neoplasia: Dissociation from endogenous gastrin levels. Surgery 91:525-530, 1982
74. Talley NJ, Chute CG, Larson DE, Epstein R, Lydick EG, Melton LJ: Risk for colorectal adenocarcinoma in pernicious anemia. Ann Intern Med 111:738-742, 1989
75. McGuigan JE, Trudeau WL: Serum gastrin concentrations in pernicious anemia. N Engl J Med 282(7):358-361, 1970
76. Norton JA, Doppman JL, Jensen RT: Curative resection in Zollinger-Ellison syndrome: Results of a 10-year prospective study. Ann Surg 215:8-18, 1992
77. Norton JA, Levin B, Jensen RT: Cancer of the endocrine system. In Cancer: Principles and Practice of Oncology. VT DeVita Jr, S Hellman, SA Rosenberg (eds). Philadelphia, JB Lippincott, 1993, pp 1333-1435
78. Malagelada J, Edis AJ, Adson MA, Van Heerden JA, Go VLW: Medical and surgical options in the management of patients with gastrinoma. Gastroenterology 84:1524-1532, 1983
79. Stabile BE, Passaro E Jr: Benign and malignant gastrinoma. Am J Surg 49:144-150, 1985
80. Bardram L: Progastrin in serum from Zollinger-Ellison patients. An indicator of malignancy? Gastroenterology 98:1420-1426, 1990
81. Hilsted L, Bardram L: C terminally glycine extended gastrins in serum and tumors from patients with Zollinger-Ellison syndrome. Can J Physiol Pharmacol 136-137, 1986
82. Hilsted L, Hint K, Christensen J, Rehfeld JF: Neither glycine-extended gastrin nor the 1-13 fragment of gastrin-17 influences gastric acid secretion in humans. Gastroenterology 94:96-102, 1988
83. Seva C, Dickinson CJ, Yamada T: Growth-promoting effects of glycine-extended progastrin. Science 265:410-412, 1994
84. Lieberman DA, Smith FW: Screening for colon malignancy with colonoscopy. Am J Gastroenterol 86:946-951, 1991
85. Clark JC, Collan Y, Eide TJ, Esteve J, Ewen S, Gibbs NM, Jensen OM, Koskela E, MacLennan R, Simpson JG, Stalsberg H, Zaridze DG: Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. Int J Cancer 36:179-186, 1985
86. Berg JW, Downing A, Lukes RJ: Prevalence of undiagnosed cancer of the large bowel found at autopsy in different races. Cancer 25:1076-1080, 1970
87. Levin KE, Dozois RR: Epidemiology of large bowel cancer. World J Surg 15:562-567, 1991
88. Solcia E, Capella C, Fiocca R, Rindi G, Rosai J: Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association. Am J Surg Pathol 14:503-513, 1990
89. Lehy T, Cadiot G, Mignon M, Ruszniewski P, Bonfils S: Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome. Gut 33:1275-1279, 1992